NextPoint Therapeutics, Inc.

New Filing
CIK: 0001959209·Biotechnology·DELAWARE·Filed: Jul 30, 2026
Total Offering

$48,729,165

Amount Sold

$33,728,772

Investors

15

First Sale

Jul 22, 2026

Offering Details

Type
Equity, Option to Acquire
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Detlev Biniszkiewicz
Ivan Cheung
Axel Hoos
R. Jacob Vogelstein
Brian Shuster
Paulina Hill
Rakhshita Dhar
Jeffrey Lacey

Company

NextPoint Therapeutics, Inc.

238 MAIN STREET

CAMBRIDGE, MA, 02142

508-204-1115

SEC Filing

0001959209-26-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free